Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study
Keywords: AE; adverse event; D; dose; DENV; dengue serotype; DEN; dengue immune response; FAS; full analysis set; GMT; geometric mean titers; MNT50; microneutralization test resulting in 50% reduction in plaques; PBS; phosphate-buffered saline; PFU; plaque forming